Cargando…
Low-Data Drug Design with Few-Shot Generative Domain Adaptation
Developing new drugs for emerging diseases, such as COVID-19, is crucial for promoting public health. In recent years, the application of artificial intelligence (AI) has significantly advanced drug discovery pipelines. Generative models, such as generative adversarial networks (GANs), exhibit the p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526055/ https://www.ncbi.nlm.nih.gov/pubmed/37760206 http://dx.doi.org/10.3390/bioengineering10091104 |